US Market Changes in the Treatment of Advanced Melanoma
Progressively unfolding patient case scenarios were presented to 200 U.S. oncologists, who manage patients with advanced melanoma, to understand differences in clinical decisions and the factors that influence those decisions. Data presented includes oncologist treatment regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.
CHAPTER 1: INTRODUCTION
CHAPTER 2: RESPONDENT DEMOGRAPHICS
CHAPTER 3: TREATMENT OF STAGE III MELANOMA WITH MICROMETASTATIC AXILLARY NODES
CHAPTER 4: TREATMENT OF ELDERLY WOMAN WITH METASTATIC DISEASE AT THE TIME OF DIAGNOSIS
CHAPTER 5: YOUNG MAN WITH RECURRENT MELANOMA METASTATIC TO LIVER AND BONE
CHAPTER 6: PATIENT WITH SOLITARY METASTATIC LESION
APPENDIX A: SURVEY INSTRUMENT
CHAPTER 2: RESPONDENT DEMOGRAPHICS
CHAPTER 3: TREATMENT OF STAGE III MELANOMA WITH MICROMETASTATIC AXILLARY NODES
CHAPTER 4: TREATMENT OF ELDERLY WOMAN WITH METASTATIC DISEASE AT THE TIME OF DIAGNOSIS
CHAPTER 5: YOUNG MAN WITH RECURRENT MELANOMA METASTATIC TO LIVER AND BONE
CHAPTER 6: PATIENT WITH SOLITARY METASTATIC LESION
APPENDIX A: SURVEY INSTRUMENT
